TD Waterhouse Canada’s GoodRx Holdings GDRX Stock Holding History

TD Waterhouse Canada’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250	Closed	-$2.02K	–	1785
2023 Q1	$2.02K	Buy	+250	New	+$1.39K	﹤0.01%	1514

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Waterhouse Canada's GDRX Position: Q2 2023 in Review

TD Waterhouse Canada sold out of GoodRx Holdings (GDRX) in Q2 2023, closing a stake of 250 shares — an estimated $2.02K sold.

TD Waterhouse Canada first reported a position in GDRX in Q1 2023 and held it in 1 quarter. The position peaked at $2.02K in Q1 2023. 147 funds tracked by Wall St. Rank hold GDRX as of Q2 2023.

TD Waterhouse Canada reported no remaining GoodRx Holdings position as of Q2 2023 after selling out during the quarter.
TD Waterhouse Canada sold 250 GoodRx Holdings shares in Q2 2023, an estimated $2.02K.
TD Waterhouse Canada first reported a position in GoodRx Holdings in Q1 2023 and held it in 1 quarter.
TD Waterhouse Canada's GoodRx Holdings position peaked at $2.02K in Q1 2023.
147 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2023.

Based on TD Waterhouse Canada's 13F filing for Q2 2023, filed 13 Nov 2023.